Position in VYGR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$43,753
-$793 QoQ
Shares Held
11,335
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $117,481,189 across 42 Biotechnology names. VYGR ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,893 | $47,732,000 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,517 | $32,850,334 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,472 | $9,751,400 | |
| 4 | INSM |
INSMED Inc
|
48,193 | $7,880,519 | |
| 5 | INCY |
Incyte Corp
|
42,643 | $4,013,559 | |
| 6 | MRNA |
Moderna, Inc.
|
78,526 | $3,989,120 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,856 | $1,821,574 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,224 | $1,449,845 |
All Filings in VYGR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,753 | 11,335 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $44,546 | 11,335 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||